ArticleFrontiers in cardiovascular medicine2025
SGLT2i use is associated with reduced risks of cardiopulmonary inflammatory complications in cancer patients with diabetes: a retrospective cohort study.
Dan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.